[1] Speers C, Pierce LJ. Postoperative radiotherapy after breast-conserving surgery for early-stage breast cancer: a review[J]. JAMA Oncol, 2016, 2(8):1075-1082. [2] 罗雪梅, 周凯, 王燕平,等. 探讨《金匮要略》之“阴阳毒”[J]. 河南中医, 2016, 36(4):565-567. [3] 肖洪. 对参附注射液有效成分及其抗心血管疾病药理作用的研究[J]. 当代医药论丛, 2017, 15(14):21-22. [4] Coles CE, Griffin CL, Kirby AM, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial[J]. Lancet, 2017, 390(99):1048. [5] 裴迎霞, 郑琦, 赵志正,等. 中医药治疗放射性肺损伤实验研究进展[J]. 国际中医中药杂志, 2017, 39(10):949-952. [6] 杨贵荣, 杨长春. 参附注射液在危重病中的应用进展[J]. 解放军药学学报, 2017,21(3):259-261. [7] Cao A, He H, Jing M, et al. Shenfu injection adjunct with platinum-based chemotherapy for the treatment of advanced non-small-cell lung cancer: a meta-analysis and systematic review[J]. Evid Based Complement Alternat Med, 2017, 5:1068751. [8] Zhang Q, Li C, Shao F, et al. Efficacy and safety of combination therapy of shenfu injection and postresuscitation bundle in patients with return of spontaneous circulation after in-hospital cardiac arrest: a randomized, assessor-blinded, controlled trial[J]. Critical Care Med, 2017, 45(10):1587. [9] 艾秀清, 张新春, 贺春钰,等. 参附注射液对乳腺癌术后放疗毒副反应及生活质量的影响[J]. 陕西中医, 2014,35(10):1373-1375. [10] Zhang N, Liu J, Qiu Z, et al. Shenfu injection for improving cellular immunity and clinical outcome in patients with sepsis or septic shock[J]. Am J Emergency Med, 2016, 35(1):1-6.
2019, Vol. 36 
